Evidence map›Paper›PMID 32326269›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Supplementation with a Carob (

María de la Fuente-Fernández, Daniel González-Hedström, Sara Amor, Antonio Tejera-Muñoz, Nuria Fernández, Luis Monge, Paula Almodóvar, Laura Andrés-Delgado, Luis Santamaría, Marin Prodanov and 3 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Carob (Reviews on recent clinical trials · 2024
    Pooled it
  2. Review
  3. Carob (Foods (Basel, Switzerland) · 2024
    Article
  4. Carob Extract (Pharmaceutics · 2023
    Article
  5. Exploring Carob (Plants (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Lipid-Lowering Effects of Carob Extracts (Frontiers in pharmacology · 2022
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

María de la Fuente-FernándezDepartamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Daniel González-HedströmDepartamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Sara AmorDepartamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Antonio Tejera-MuñozDepartamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Nuria FernándezDepartamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Luis MongeDepartamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.ORCID 0000-0001-7688-7531
Paula AlmodóvarPharmactive Biotech Products S.L. Parque Científico de Madrid, 28049 Madrid, Spain.
Laura Andrés-DelgadoDepartamento de Anatomía, Histología y Neurociencia, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Luis SantamaríaDepartamento de Anatomía, Histología y Neurociencia, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Marin ProdanovDepartamento de Química Física Aplicada, Facultad de Ciencias, CIAL (CEI, CSIC-UAM), Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Antonio Manuel Inarejos-GarcíaPharmactive Biotech Products S.L. Parque Científico de Madrid, 28049 Madrid, Spain.
Angel Luis García-VillalónDepartamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Miriam GranadoDepartamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.ORCID 0000-0001-9178-8822
Universidad Autónoma de Madrid · ESInstituto de Salud Carlos III · ES

Funding

Dirección General de Universidades e Investigación IND2017/BIO7701 and PEJ-2018-AI/SAL-11315Pharmactive Biotech Products S.L. 2018/0168
6 · The paper itself

Abstract

The incidence of metabolic syndrome (MetS) is increasing worldwide which makes necessary the finding of new strategies to treat and/or prevent it. The aim of this study was to analyze the possible beneficial effects of a carob fruit extract (CSAT+

Indexed as

anti-inflammatoryantioxidantcardiovascularcarobcoronary ischemiaendothelial dysfunctioninsulin resistancemetabolic syndrome

Identifiers

PMID32326269
PMCPMC7222348
OpenAlexW3019858347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.